Bilirubin cause

When heme proteins are degraded in mammals, the polypeptides are hydrolyzed to amino acids while the heme groups are freed of their iron, which is salvaged, and are converted to bilirubin. After transport to the liver, bilirubin is coupled to glucuronic acid and the conjugated bilirubin is excreted into bile as the principal bile pigment. When increased production or decreased excretion of bilirubin causes its plasma concentration to exceed 0.1-1.0 mg/dL (2-17 /rmol/L), it diifuses into tissues and... 

Increases in plasma bilirubin cause jaundice and this may arise... 

Older adults are particularly susceptible to a potentially fatal hepatitis when taking isoniazd, especially if they consume alcohol on a regular basis. Two other antitubercular drugs rifampin and pyrazinamide, can cause liver dysfunction in the older adult. Careful observation and monitoring for signs of liver impairment are necessary (eg, increased serum aspartate transaminase, increased serum alanine transferase, increased serum bilirubin, and jaundice). 

Hyjjerbilirubinaemia is an abnormality observed mainly in neonates in whom the liver is insufficiently developed to be able to detoxify the bile pigment bilirubin. This situation is known as neonatal jaundice and can sometimes become a serious disease causing neurotoxic symptoms. Bilirubin is produced by the degradation of heme [the Fe(II) complex of protoporphyrin IX] by heme oxygenase to give biliverdin, which is reduced by biliverdin reductase to... 

Knowledge of the biochemistry of the porphyrins and of heme is basic to understanding the varied functions of hemoproteins (see below) in the body. The porphyrias are a group of diseases caused by abnormalities in the pathway of biosynthesis of the various porphyrins. Although porphyrias are not very prevalent, physicians must be aware of them. A much more prevalent clinical condition is jaundice, due to elevation of bilirubin in the plasma. This elevation is due to overproduction of bilirubin or to failure of its excretion and is seen in numerous diseases ranging from hemolytic anemias to viral hepatitis and to cancer of the pancreas. 

Figure 32-15. Diagrammatic representation of the three major processes (uptake, conjugation, and secretion) involved in the transfer of bilirubin from blood to bile. Certain proteins of hepatocytes, such as ligandin (a family of glutathione S-transferase) and Y protein, bind intracellular bilirubin and may prevent its efflux into the blood stream. The process affected in a number of conditions causing jaundice is also shown.

When bifimbin in the blood exceeds 1 mg/dL (17.1 lmol/L), hyperbifimbinemia exists. Hyperbilirubinemia may be due to the production of more bilirubin than the normal fiver can excrete, or it may result from the failure of a damaged fiver to excrete bilirubin produced in normal amounts. In the absence of hepatic damage, obstmction of the excretory ducts of the fiver—by preventing the excretion of bilirubin—will also cause hyperbilirubinemia. In all these situations, bifimbin accumulates in the blood, and when it reaches a certain concentration (approximately 2-2.5 mg/dL),... 

Again, this is caused by mutations in the gene encoding bilirubin-UGT, but approximately 30% of the enzyme s activity is preserved and the condition is entirely harmless. 

This benign autosomal recessive disorder consists of conjugated hyperbilirubinemia in childhood or during adult life. The hyperbilirubinemia is caused by mutations in the gene encoding MRP-2 (see above), the protein involved in the secretion of conjugated bilirubin into bile. The centrilobular hepatocytes contain an abnormal black pigment that may be derived from epinephrine. 

The commonest causes of obstructive (posthepatic) jaundice are cancer of the head of the pancreas and a gallstone lodged in the common bile duct. The presence of bilirubin in the urine is sometimes referred to as choluria—therefore, hepatitis and obstruction of the common bile duct cause choluric Jaundice, whereas the Jaundice of hemolytic anemia is referred to as acholuric. The laboratory results in patients with hepatitis are variable, depending on the extent of damage to parenchymal cells and the extent of micro-obstruction to bile ductules. Serum levels of ALT and AST are usually markedly elevated in hepatitis, whereas serum levels of alkaline phosphatase are elevated in obstructive liver disease. 

In jaundice secondary to hemolysis, the increased production of bilirubin leads to increased production of urobilinogen, which appears in the urine in large amounts. Bilirubin is not usually found in the urine in hemolytic jaundice (because unconjugated bihmbin does not pass into the urine), so that the combination of increased urobilinogen and absence of bihmbin is suggestive of hemolytic jaundice. Increased blood destruction from any cause brings about an increase in urine urobilinogen. 

The sinusoids transport both portal and arterial blood to the hepatocytes. The systemic blood delivered to the liver contains nutrients, drugs, and ingested toxins. The liver processes the nutrients (carbohydrates, proteins, lipids, vitamins, and minerals) for either immediate use or for storage, while the drugs and toxins are metabolized through a variety of processes known as first-pass metabolism. The liver also processes metabolic waste products for excretion. In cirrhosis, bilirubin (from the enzymatic breakdown of heme) can accumulate this causes jaundice (yellowing of the skin), scleral icterus (yellowing of the sclera), and tea-colored urine (urinary bilirubin excretion). 

Maruo Y, Sato H, Yamano T et al. Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. 

These results do not have any diagnostic meaning. The dynamics of the ACU values after an operative intervention could be taken into account regarding the existence of metastases. As demonstrated in Figure 12, prognostic relevance can be ascribed to ACU. The rise in ACU value is caused in this case by increase of the bilirubin level under the conditions of the life-threatening inflammatory processes [1],... 

A jaundiced one-day-old premature infant with an elevated free bilirubin is seen in the premature-baby nursery The mother received an antibiotic combination preparation containing sulfamethizole for a urinary tract infection (UTI) one week before deliver)1 You suspect that the infant s findings are caused by the sulfonamide because of the following mechanism ... 

Elevations of serum bilirubin are common in end-stage liver disease and obstruction of the common bile duct, but other causes of hyperbilirubinemia are numerous. 

Increased bilirubin levels are caused due to the intake of large doses of such drugs as chloroquine, vitamin K, sulpha-drugs, tetracyclines, paracetamol, nicotinic acid and monoamine oxidase inhibitors (e.g., iproniazid RP 1.0 nialamide RP 1.8 isocarboxazid RP 3.1 phenelzine RP 18 pheniprazine RP31 and tranylcypromine RP 45), where RP designates the Relative Potency based on the tiyptamine potentiation test. The elevated levels are due to hepatic injury, and... 

There are a few medicinals that cause increased bilirubin levels which ultimately enhances AP-levels unless and until a corrective measure is taken in the respective procedure one may be left with false AP-level enhancement. Some typical examples are, namely amitriptyline, chloropropamide, erythromycin, phenylbutazone, sulpha-drugs and tetracyclines. 

The over-production of bilirubin to the point at which the liver s capacity to metabolize is exceeded or if there is dysfunction of the liver itself due to damage or metabolic immaturity, can lead to a yellow discolouration of tissues called jaundice. The accumulation of unconjugated bilirubin in neonates, often as a result of antibody-mediated destruction of the baby s red cells is dangerous as serious and irreversible brain damage can occur. Acute or chronic damage to the adult liver (hepatitis) may cause jaundice but not brain damage. 

Fluorescein (excitation and emission maxima of 492 nm and 520 nm, respectively) has also been utilized in fluorescence assays. Although its excitation maximum is higher than that of umbelliferone, it suffers from a problem similar to that of umbelliferone in that albumin-bound bilirubin has excitation and emission maxima of 460 nm and 515 nm, respectively. In addition, commercial preparations have been reported to contain two isomers, which may cause heterogeneity during conjugate preparation. 

Following ingestion of the substance, the gastrointestinal (GI) tract is the site of initial or phase I toxicity to the mucosal surfaces. This toxicity is manifested by swelling, edema, and painful ulceration of the mouth, pharynx, esophagus, stomach, and intestine. With higher levels, other GI toxicity includes centrizonal hepatocellular injury, which can cause elevated bilirubin, and hepatocellular enzyme levels such as AST, ALT, and LDH. 

Studies of UDP-glucuronyltransferase with bilirubin as the acceptor substrate are technically difficult. This is indicated by frequent modification of the initial assay systems (A8, G9, L4, S4) and by the wide range of reported enzyme activities (Table 1). Possible causes of these discrepancies, which are manyfold, will be discussed in some detail below. The conclusions drawn should be helpful in the design of assays of conjugate formation of bilirubin and of the synthesis of mono- and diconjugates. 

Partial or total deficiency, or inhibition of bilirubin UDP-glucuronyltransferase may cause unconjugated hyperbilirubinemia. Increased production (hemolysis, ineffective erythropoiesis) should be excluded by investigating hematologic parameters. Determination in vitro of bilirubin UDP-glycosyltransferase activities can contribute to a differential diagnosis. To minimize the effect of cytoplasmic carrier proteins, in in vitro... 

Drug/Lab test interactions Large doses of iron dextran (5 mL or more) give a brown color to serum from a blood sample drawn 4 hours after administration they may cause falsely elevated values of serum bilirubin and falsely decreased values of serum calcium. 

---